GlassScriptPhysician profile
Crystal Tong
NPI 1346637352
$1,287.51
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $60.49 · 2020: $78.11 · 2021: $97.56 · 2023: $1,018 · 2024: $33.62.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,051.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,051.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mallinckrodt Hospital Products INC. | $209.52 | 2023 | Acthar |
| Optos, INC. | $175.67 | 2020-2021 | |
| Dompe US, INC. | $157.87 | 2023-2024 | Oxervate |
| Oyster Point Pharma, INC. | $151.76 | 2023 | Tyrvaya |
| Sun Pharmaceutical Industries INC. | $131.49 | 2023 | Cequa |
| Ocular Therapeutix, INC. | $91.56 | 2023 | Dextenza |
| Rxsight INC | $83.25 | 2023 | Rxsight Injector Cartridge, Rxsight Contact Lens, Rxsight Injector Handpiece |
| Alcon Vision LLC | $72.73 | 2023 | Eysuvis |
| Coopervision INC. | $60.49 | 2019 | |
| Johnson & Johnson Surgical Vision, INC. | $36.57 | 2023 | Tecnis Iol |
| Carl Zeiss Meditec USA, INC. | $36.53 | 2023 | Visumax |
| Bausch & Lomb Americas INC. | $32.64 | 2023 | Envista Mx60 Iol, Prolensa, Lotemax Sm |
| Rayner Intraocular Lenses Limited | $26.57 | 2023 | Rayone Spheric, Omidria, Rayone Aspheric |
| Harrow Eye, LLC | $20.86 | 2023 | Iheezo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Crystal Tong listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.